Mathematical modeling of risk-taking in bipolar disorder: evidence of reduced behavioral consistency, with altered loss aversion specific to those with history of substance use disorder - Lasagna CA, Pleskac TJ, Burton CZ, McInnis MG, Taylor SF, Tso IF.
Bipolar disorder (BD) is associated with excessive pleasure-seeking risk-taking behaviors that often characterize its clinical presentation. However, the mechanisms of risk-taking behavior are not well-understood in BD. Recent data suggest prior substance ... (Source: SafetyLit)
Source: SafetyLit - February 8, 2023 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Associations between exposure to early childhood adversities and middle childhood psychotic experiences in children at familial high risk of schizophrenia, bipolar disorder, and population-based controls: the Danish high risk and resilience study - VIA 7 and VIA 11 - Brandt JM, Gregersen M, S øndergaard A, Krantz MF, Knudsen CB, Andreassen AK, Veddum L, Ohland J, Hjorthøj C, Wilms M, Rohd SB, Greve A, Burton BK, Bliksted V, Mors O, Nordentoft M, Thorup AAE, Hemager N.
BACKGROUND: Exposure to adversities in early childhood is associated with psychotic experiences and disorders in adulthood. We aimed to examine whether early childhood adversities are associated with middle childhood psychotic experiences in a cohort of ch... (Source: SafetyLit)
Source: SafetyLit - February 6, 2023 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Are bipolar disorder, major depression, and suicidality linked with Toxoplasma gondii? A seromolecular case-control study - Demirel F, Akg ül, Bulu E, Tanriöver Aydin E, Uysal Cesur N, Aksoy Poyraz C, Oner YA.
OBJECTIVE: The existence of predisposing effects of latent Toxoplasma gondii (T. gondii) infection in bipolar disorder (BD), major depression (MD), and even suicide attempt (SA) has long been debatable. This conjecture remains unclear because there is a la... (Source: SafetyLit)
Source: SafetyLit - February 6, 2023 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Psychiatric comorbidity in individuals with bipolar disorder: relation with clinical outcomes and functioning - L éda-Rego G, Studart-Bottó P, Sarmento S, Cerqueira-Silva T, Bezerra-Filho S, Miranda-Scippa.
The aim was to assess the lifetime prevalence of psychiatric comorbidity (PC) in Brazilian euthymic individuals with bipolar disorder type I, and investigate its effects on clinical outcomes and functioning. A group of 179 outpatients with BD-I in the recu... (Source: SafetyLit)
Source: SafetyLit - February 6, 2023 Category: International Medicine & Public Health Tags: Risk Factor Prevalence, Injury Occurrence Source Type: news

B.C. woman says 'door is shut in our faces' as she fights for sister's mental health care
For the past 13 years, Kala Hooker has tried every legal option to be involved in the care of her sister Kora-lea, who has bipolar disorder and has been in and out of hospitals and treatment centres across B.C., Alberta, the U.S., Haiti and Jamaica. (Source: CBC | Health)
Source: CBC | Health - February 6, 2023 Category: Consumer Health News Tags: News/Canada/British Columbia Source Type: news

Financial Crime: Death and deceit in Malibu: How yogi couple befriended and stole millions from vulnerable rich doctor
The tragic end of Dr. Mark Sawusch’s life all started in an ice cream shop in Venice Beach. On June 23, 2017, Sawusch — a brilliant, but troubled ophthalmologist who struggled with bipolar disorder — met Anton David and Anna Moore. It was a fateful encounter that would eventually lead to his death…#marksawuschs #venicebeach #antondavid #annamoore #anthonyflores #fresno #sawuschstesla #northerncalifornia #moore #sawusch (Source: Reuters: Health)
Source: Reuters: Health - February 2, 2023 Category: Consumer Health News Source Type: news

Anticipating unipolar depression and bipolar depression in young adult with first episode of depression using childhood trauma and personality - Liu J, Wang Y, Wilson A, Chen H, Liu P, Chen X, Tang H, Luo C, Tian Y, Wang X, Cao X, Zhou J.
OBJECTIVE: Relevant research focusing on young adults with Unipolar Depression (UD) and Bipolar Depression (BD) is limited. The current research aims to investigate childhood trauma and personality traits in young adults with UD and BD. METHODS: Tw... (Source: SafetyLit)
Source: SafetyLit - February 1, 2023 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Subjective response to alcohol in young adults with bipolar disorder and recent alcohol use: a within-subject randomized placebo-controlled alcohol administration study - Lippard ETC, Kirsch DE, Kosted R, Le V, Almeida JRC, Fromme K, Strakowski SM.
This study used a randomized, placebo-controlled, cr... (Source: SafetyLit)
Source: SafetyLit - January 27, 2023 Category: International Medicine & Public Health Tags: Age: Young Adults Source Type: news

New Report: More than 160 medicines in development for mental illness
Mental illness represents a broad spectrum of health conditions affecting mood, thinking and behavior. These conditions include depression, bipolar disorder, schizophrenia, substance use disorder, anxiety disorders, eating disorders, obsessive compulsive disorder and post-traumatic stress disorder, among others. Each of these illnesses often varies in its degree of severity, ranging from mild to moderate to severe, and may occur together. In severe cases, mental illnesses can cause serious functional impairment and substantially interfere with or place limits on life activities –– these are consideredserious mental ill...
Source: The Catalyst - January 26, 2023 Category: Pharmaceuticals Authors: Matthew Norawong Tags: Medicines in Development Mental Health Source Type: news

Psychiatric Illnesses Share Common Brain Network Psychiatric Illnesses Share Common Brain Network
A network of neural connections is linked to six psychiatric disorders, including schizophrenia, bipolar disorder, and depression, new research suggests.Medscape Medical News (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - January 25, 2023 Category: Pathology Tags: Psychiatry News Source Type: news

What Is Bipolar Androgen Therapy for Prostate Cancer? What Is Bipolar Androgen Therapy for Prostate Cancer?
The approach takes advantage of castration-resistant prostate cancer cells ' adaptive reliance on androgen signaling.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 23, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Africa Eye: Filmmaker Noella Luka documents her battle with bipolar disorder
Noella Luka documents her own descent into bipolar disorder challenging the stigmas surrounding the issue of mental health in Kenya. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - January 23, 2023 Category: Consumer Health News Source Type: news

FDA OKs Long-Acting Risperidone; TMS for Anxious Depression; CBT Bests Pharma
(MedPage Today) -- The FDA approved the biweekly long-acting injectable (LAI) risperidone (Rykindo) for the treatment of schizophrenia and bipolar I disorder, Luye Pharma Group announced. A phase IIa study showed a significantly greater improvement... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - January 18, 2023 Category: Psychiatry Source Type: news

BPD Tied to Longer Time to Depression Remission BPD Tied to Longer Time to Depression Remission
Patients with borderline personality disorder and major depressive episodes have a longer time to depression remission than those with major depressive disorder (MDD) or bipolar disorder plus MDD.MDedge News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - January 17, 2023 Category: Psychiatry Tags: Psychiatry News Source Type: news

FDA Approves Rykindo (risperidone) Extended-Release Injectable Suspension for the Treatment of Schizophrenia and Bipolar 1 Disorder
PRINCETON, N.J., Jan. 15, 2023 /PRNewswire/ -- Luye Pharma Group (Luye Pharma), an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications, today announced that the U.S. Food and Drug... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - January 15, 2023 Category: Drugs & Pharmacology Source Type: news